REGENTIS BIOMATERIALS LTD.
RGNT · XNYSCIK 1912966fmd_01B5K01AAJQ1FW5WQJG9ZDKMMCManufacturing · Orthopedic, Prosthetic & Surgical Appliances & SuppliesTemplate: Standard
Coverage: Jan 01, 2023 to Dec 31, 2025, 3 periods
Latest annual · FY2025
Millions- Operating income
- (7)
- Net income
- (14)
Daily close · RGNTIEX trades only
Nov 09, 2026 to Nov 11, 2026 · 3 sessions1.23 USD
Built from trades executed at IEX only, one exchange with a small share of US volume. This is not the consolidated tape. The close is the last IEX trade of the session, not the official closing price. Earlier sessions are divided by the later split ratios the API confirmed against IEX prices; dividends are not adjusted. Switch to As traded for the prices as they printed. End of day, not real time: a session is published the day after it trades.
Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms
REGENTIS BIOMATERIALS LTD. (RGNT) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Operating income | -$7 million | $932,000 | -847.6% | 20-F 2026-02-24 · proof |
| Net income | -$13.6 million | $4.8 million | -384.3% | 20-F 2026-02-24 · proof |
| Cash from operating activities | -$1.4 million | -$641,000 | 20-F 2026-02-24 · proof | |
| Total assets | $7.6 million | $482,000 | +1,480.5% | 20-F 2026-02-24 · proof |
| Total liabilities | $2.9 million | $6.5 million | -55.7% | 20-F 2026-02-24 · proof |
| Cash and cash equivalents | $7.4 million | 20-F 2026-02-24 · proof |
- What was REGENTIS BIOMATERIALS LTD. (RGNT)'s operating income in fiscal 2025?
- REGENTIS BIOMATERIALS LTD. (RGNT) reported operating income of -$7 million for fiscal 2025 (the year ended Dec 31, 2025), against $932,000 the year before (-847.6%). Source: the 20-F filed with the SEC on Feb 24, 2026. SEC
- What was REGENTIS BIOMATERIALS LTD. (RGNT)'s net income in fiscal 2025?
- REGENTIS BIOMATERIALS LTD. (RGNT) reported net income of -$13.6 million for fiscal 2025 (the year ended Dec 31, 2025), against $4.8 million the year before (-384.3%). Source: the 20-F filed with the SEC on Feb 24, 2026. SEC
- What was REGENTIS BIOMATERIALS LTD. (RGNT)'s cash from operating activities in fiscal 2025?
- REGENTIS BIOMATERIALS LTD. (RGNT) reported cash from operating activities of -$1.4 million for fiscal 2025 (the year ended Dec 31, 2025), against -$641,000 the year before. Source: the 20-F filed with the SEC on Feb 24, 2026. SEC
- What are REGENTIS BIOMATERIALS LTD. (RGNT)'s total assets?
- As of Dec 31, 2025, REGENTIS BIOMATERIALS LTD. (RGNT) reported total assets of $7.6 million, against $482,000 a year earlier (+1,480.5%). Source: the 20-F filed with the SEC on Feb 24, 2026. SEC
- What are REGENTIS BIOMATERIALS LTD. (RGNT)'s total liabilities?
- As of Dec 31, 2025, REGENTIS BIOMATERIALS LTD. (RGNT) reported total liabilities of $2.9 million, against $6.5 million a year earlier (-55.7%). Source: the 20-F filed with the SEC on Feb 24, 2026. SEC
- What are REGENTIS BIOMATERIALS LTD. (RGNT)'s cash and cash equivalents?
- As of Dec 31, 2025, REGENTIS BIOMATERIALS LTD. (RGNT) reported cash and cash equivalents of $7.4 million. Source: the 20-F filed with the SEC on Feb 24, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:RGNT&period_type=annual&limit=5"Information only, not investment advice.